摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-二氯-L-苯基丙氨酸 | 111119-36-9

中文名称
2,4-二氯-L-苯基丙氨酸
中文别名
L-2,4-二氯苯丙氨酸;2,4-二氯-L-苯丙氨酸
英文名称
(S)-2-amino-3-(2,4-dichlorophenyl)propanoic acid
英文别名
2,4-dichloro-L-phenylalanine;L-2,4-dichloro-Phe;L-2,4-diCl-Phe;(S)-2-Amino-3-(2,4-dichloro-phenyl)-propionic acid;L-2,4-dichlorophenylalanine;(2S)-2-azaniumyl-3-(2,4-dichlorophenyl)propanoate
2,4-二氯-L-苯基丙氨酸化学式
CAS
111119-36-9
化学式
C9H9Cl2NO2
mdl
——
分子量
234.082
InChiKey
GWHQTNKPTXDNRM-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    238-240 °C
  • 沸点:
    368.1±42.0 °C(Predicted)
  • 密度:
    1.450±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    常温常压下稳定,避免与强氧化剂接触。

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2922499990
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:a3e99c3714fe4b1b3d17d26cab7c725c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2,4-Dichloro-L-phenylalanine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2,4-Dichloro-L-phenylalanine
CAS number: 111119-36-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9Cl2NO2
Molecular weight: 234.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,4-二氯-L-苯基丙氨酸盐酸 、 sodium nitrite 作用下, 反应 4.0h, 生成 (2S)-3-(2,4-dichlorophenyl)-2-hydroxypropanoic acid
    参考文献:
    名称:
    Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
    摘要:
    本发明涉及结构式(I)的取代芳基或杂芳基哌啶衍生物,作为黑色素皮质素-4受体调节剂。根据结构和立体化学,本发明的化合物可以是人类黑色素皮质素-4受体(MC-4R)的选择性激动剂或选择性拮抗剂。激动剂可用于治疗肥胖、糖尿病和性功能障碍等疾病,而拮抗剂可用于治疗癌症恶病质、肌肉消耗、厌食症、焦虑和抑郁等疾病。一般来说,所有涉及MC-4R调节的疾病和疾病都可以用本发明的化合物进行治疗。
    公开号:
    EP2020405A1
  • 作为产物:
    描述:
    反-2,4-二氯肉桂酸ammonium hydroxide二氧化碳 作用下, 以 二甲基亚砜 为溶剂, 反应 12.0h, 以98%的产率得到
    参考文献:
    名称:
    伸缩一锅缩合氢化胺化策略,由苯甲醛合成光学纯的L-苯丙氨酸
    摘要:
    从商业上可买到的便宜的取代苯甲醛开始,设计了一种化学酶促伸缩方法,以高产率和光学纯度合成L-芳基丙氨酸。该方法利用化学的Knoevenagel-Doebner缩合(使用微波辐照在短的反应时间内进行优化,以实现完全转化)和生物催化的苯丙氨酸氨裂合酶介导的加氢胺化反应(用于立体选择性地添加氨)。这两个反应可以在一个罐中依次进行,从而将化学和生物催化的优点结合在一起。制备了五个相关的L-二卤代苯丙氨酸(71-84%收率,98-99%ee)作为分子探针,可用于药物化学和合成药物成分,证明了其制备性适用性。
    DOI:
    10.1016/j.tet.2015.12.063
点击查看最新优质反应信息

文献信息

  • [EN] AZASULFURYLPEPTIDE-BASED CD36 MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS CD36 À BASE D'AZASULFURYLPEPTIDES ET UTILISATIONS DE CEUX-CI
    申请人:RSEM LTD PARTNERSHIP
    公开号:WO2016029324A1
    公开(公告)日:2016-03-03
    Novel azasulfuryl-containing peptidomimetics capable of inhibiting CD36 activity are disclosed. Use of these azasulfuryl-containing peptidomimetics for the treatment of CD36-related diseases, disorders or conditions, including TLR2-mediated inflammatory disease, disorder or condition, and methods of obtaining such azasulfuryl-containing peptidomimetics, are also disclosed.
    揭示了能够抑制CD36活性的新型含氮硫酰基的肽类模拟物。还揭示了利用这些含氮硫酰基的肽类模拟物治疗与CD36相关的疾病、紊乱或状况,包括TLR2介导的炎症性疾病、紊乱或状况的用途,以及获取这种含氮硫酰基的肽类模拟物的方法。
  • Angiotensin-1-Receptor Antagonists
    申请人:Ferring B.V.
    公开号:US20170349629A1
    公开(公告)日:2017-12-07
    In one aspect, this disclosure features compounds of formula (I) or a pharmaceutically acceptable salt thereof: AA1-Arg-Val-AA4-AA5-His-Pro-AA8-OH   (I), in which AA1, AA4, AA5, and AA8 are defined in the specification. The compounds of formula (I) can be used to treat hypertension (e.g., hypertension induced by pregnancy), preeclampsia, or a renal disease induced by pregnancy.
    在一个方面,这个披露涉及到式(I)的化合物或其药用盐: AA1-Arg-Val-AA4-AA5-His-Pro-AA8-OH (I), 其中AA1,AA4,AA5和AA8在规范中有定义。式(I)的化合物可用于治疗高血压(例如,妊娠引起的高血压),子痫前期,或妊娠引起的肾脏疾病。
  • Sulfonamide compounds
    申请人:Allison Brett
    公开号:US20060069286A1
    公开(公告)日:2006-03-30
    Certain sulfonamide compounds are dual CCK1/CCK2 inhibitors useful in the treatment of CCK1/CCK2 mediated diseases.
    某些磺酰胺化合物是双CCK1/CCK2抑制剂,在治疗CCK1/CCK2介导的疾病中很有用。
  • Lipid probes and uses thereof
    申请人:THE SCRIPPS RESEARCH INSTITUTE
    公开号:US10168342B2
    公开(公告)日:2019-01-01
    Disclosed herein are methods, compositions, probes, assays and kits for identifying a lipid binding protein as a drug binding target. Also disclosed herein are methods, compositions, and probes for mapping a ligand binding site on a lipid binding protein, identification of lipid binding proteins, generating drug-lipid binding protein profiles, high throughput drug screening, and identification of drugs as potential lipid binding protein ligands.
    披露了用于识别脂质结合蛋白作为药物结合靶点的方法、组合物、探针、检测和试剂盒。此外,还披露了用于绘制脂质结合蛋白上的配体结合位点、识别脂质结合蛋白、生成药物-脂质结合蛋白轮廓、高通量药物筛选以及识别作为潜在脂质结合蛋白配体的药物的方法、组合物和探针。
  • 5-噻唑酰胺类化合物及生物学应用
    申请人:中山大学肿瘤防治中心
    公开号:CN101921268B
    公开(公告)日:2016-08-03
    本发明涉及一种5?噻唑酰胺类化合物及生物学应用,其结构式为本发明提供了由通式(I)表示的靶向AKT/PKB激酶(ATP结合位点)的5?噻唑酰胺类化合物。实验证明,本发明所涉及的噻唑酰胺类AKT抑制剂能在体外显著抑制AKT激酶的活性,并对多种AKT活性高的肿瘤细胞株具有很强的增殖抑制作用,表明噻唑酰胺类化合物可用于制备抗肿瘤药物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物